Ovid Therapeutics (OVID) Share-based Compensation (2016 - 2026)
Ovid Therapeutics (OVID) reported Share-based Compensation of $1.43 million for Q2 2026, up 17.4% from $1.22 million a year earlier and up 36.8% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ovid Therapeutics' Share-based Compensation came in at $4.78 million, down 5.7% year-over-year; for FY2025, it was $4.81 million, down 23.4% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $6.28 million in FY2024 (-13.9%), $7.29 million in FY2023 (+11.1%), $6.56 million in FY2022 (+29.7%) and $5.05 million in FY2021 (-32.8%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q2 2024.
- Year over year, Share-based Compensation gained in 1 of the last eight quarters, with an average decline of 16.9%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2022 (growth of 53.4%); the low point was Q3 2021 (a decline of 55.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.05 million (Q1 2026), $1.2 million (Q4 2025) and $1.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | 1.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.43 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.16 Mn |
API Access
Ovid Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();